• レポートコード:QYR2104Z3406 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、99ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥546,000 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥819,000 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、ロイコカートのグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(24フックロイコカート、48フックロイコカート)、用途別市場規模(病院、血液バンク、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・ロイコカートの市場動向 ・企業の競争状況、市場シェア ・ロイコカートの種類別市場規模(24フックロイコカート、48フックロイコカート) ・ロイコカートの用途別市場規模(病院、血液バンク、その他) ・ロイコカートの北米市場規模2016-2027(アメリカ、カナダ) ・ロイコカートのヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・ロイコカートのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・ロイコカートの中南米市場規模2016-2027(メキシコ、ブラジル) ・ロイコカートの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Oxford Meditech、Baxter Healthcare、ITL Limited) ・結論 |
Leukocarts is a workstation which is designed to provide assistance to the staff at the blood centers during the process of leuko reduction. Leukocarts is considered as the integral for the blood centers infrastructure because leukocarts works with all the major blood bag and the filter manufactures products.
Based on treatment type, the global Leukocarts Market is segmented into 24 hooks leukocarts and 48 hooks leukocarts. As 48 hooks leukocarts are widely used in blood banks due to increasing loading and unloading capacity of blood bags. Similarly, based on end user, the market is segmented into, hospitals and blood banks. Blood banks and hospitals both are expected to hold maximum share in the market due to increasing prescription patterns for the treatment of blood transfusion.
Market Analysis and Insights: Global Leukocarts Market
The global Leukocarts market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Leukocarts market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Leukocarts market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Leukocarts market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Leukocarts market.
Global Leukocarts Scope and Market Size
Leukocarts market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Leukocarts market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
24 Hooks Leukocarts
48 Hooks Leukocarts
Segment by Application
Hospitals
Blood Banks
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Oxford Meditech
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukocarts Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 24 Hooks Leukocarts
1.2.3 48 Hooks Leukocarts
1.3 Market by Application
1.3.1 Global Leukocarts Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Blood Banks
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Leukocarts Market Perspective (2016-2027)
2.2 Leukocarts Growth Trends by Regions
2.2.1 Leukocarts Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Leukocarts Historic Market Share by Regions (2016-2021)
2.2.3 Leukocarts Forecasted Market Size by Regions (2022-2027)
2.3 Leukocarts Industry Dynamic
2.3.1 Leukocarts Market Trends
2.3.2 Leukocarts Market Drivers
2.3.3 Leukocarts Market Challenges
2.3.4 Leukocarts Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leukocarts Players by Revenue
3.1.1 Global Top Leukocarts Players by Revenue (2016-2021)
3.1.2 Global Leukocarts Revenue Market Share by Players (2016-2021)
3.2 Global Leukocarts Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Leukocarts Revenue
3.4 Global Leukocarts Market Concentration Ratio
3.4.1 Global Leukocarts Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukocarts Revenue in 2020
3.5 Leukocarts Key Players Head office and Area Served
3.6 Key Players Leukocarts Product Solution and Service
3.7 Date of Enter into Leukocarts Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Leukocarts Breakdown Data by Type
4.1 Global Leukocarts Historic Market Size by Type (2016-2021)
4.2 Global Leukocarts Forecasted Market Size by Type (2022-2027)
5 Leukocarts Breakdown Data by Application
5.1 Global Leukocarts Historic Market Size by Application (2016-2021)
5.2 Global Leukocarts Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Leukocarts Market Size (2016-2027)
6.2 North America Leukocarts Market Size by Type
6.2.1 North America Leukocarts Market Size by Type (2016-2021)
6.2.2 North America Leukocarts Market Size by Type (2022-2027)
6.2.3 North America Leukocarts Market Size by Type (2016-2027)
6.3 North America Leukocarts Market Size by Application
6.3.1 North America Leukocarts Market Size by Application (2016-2021)
6.3.2 North America Leukocarts Market Size by Application (2022-2027)
6.3.3 North America Leukocarts Market Size by Application (2016-2027)
6.4 North America Leukocarts Market Size by Country
6.4.1 North America Leukocarts Market Size by Country (2016-2021)
6.4.2 North America Leukocarts Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Leukocarts Market Size (2016-2027)
7.2 Europe Leukocarts Market Size by Type
7.2.1 Europe Leukocarts Market Size by Type (2016-2021)
7.2.2 Europe Leukocarts Market Size by Type (2022-2027)
7.2.3 Europe Leukocarts Market Size by Type (2016-2027)
7.3 Europe Leukocarts Market Size by Application
7.3.1 Europe Leukocarts Market Size by Application (2016-2021)
7.3.2 Europe Leukocarts Market Size by Application (2022-2027)
7.3.3 Europe Leukocarts Market Size by Application (2016-2027)
7.4 Europe Leukocarts Market Size by Country
7.4.1 Europe Leukocarts Market Size by Country (2016-2021)
7.4.2 Europe Leukocarts Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Leukocarts Market Size (2016-2027)
8.2 Asia-Pacific Leukocarts Market Size by Type
8.2.1 Asia-Pacific Leukocarts Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Leukocarts Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Leukocarts Market Size by Type (2016-2027)
8.3 Asia-Pacific Leukocarts Market Size by Application
8.3.1 Asia-Pacific Leukocarts Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Leukocarts Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Leukocarts Market Size by Application (2016-2027)
8.4 Asia-Pacific Leukocarts Market Size by Region
8.4.1 Asia-Pacific Leukocarts Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Leukocarts Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Leukocarts Market Size (2016-2027)
9.2 Latin America Leukocarts Market Size by Type
9.2.1 Latin America Leukocarts Market Size by Type (2016-2021)
9.2.2 Latin America Leukocarts Market Size by Type (2022-2027)
9.2.3 Latin America Leukocarts Market Size by Type (2016-2027)
9.3 Latin America Leukocarts Market Size by Application
9.3.1 Latin America Leukocarts Market Size by Application (2016-2021)
9.3.2 Latin America Leukocarts Market Size by Application (2022-2027)
9.3.3 Latin America Leukocarts Market Size by Application (2016-2027)
9.4 Latin America Leukocarts Market Size by Country
9.4.1 Latin America Leukocarts Market Size by Country (2016-2021)
9.4.2 Latin America Leukocarts Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leukocarts Market Size (2016-2027)
10.2 Middle East & Africa Leukocarts Market Size by Type
10.2.1 Middle East & Africa Leukocarts Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Leukocarts Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Leukocarts Market Size by Type (2016-2027)
10.3 Middle East & Africa Leukocarts Market Size by Application
10.3.1 Middle East & Africa Leukocarts Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Leukocarts Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Leukocarts Market Size by Application (2016-2027)
10.4 Middle East & Africa Leukocarts Market Size by Country
10.4.1 Middle East & Africa Leukocarts Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Leukocarts Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Oxford Meditech
11.1.1 Oxford Meditech Company Details
11.1.2 Oxford Meditech Business Overview
11.1.3 Oxford Meditech Leukocarts Introduction
11.1.4 Oxford Meditech Revenue in Leukocarts Business (2016-2021)
11.1.5 Oxford Meditech Recent Development
11.2 Baxter Healthcare
11.2.1 Baxter Healthcare Company Details
11.2.2 Baxter Healthcare Business Overview
11.2.3 Baxter Healthcare Leukocarts Introduction
11.2.4 Baxter Healthcare Revenue in Leukocarts Business (2016-2021)
11.2.5 Baxter Healthcare Recent Development
11.3 ITL Limited
11.3.1 ITL Limited Company Details
11.3.2 ITL Limited Business Overview
11.3.3 ITL Limited Leukocarts Introduction
11.3.4 ITL Limited Revenue in Leukocarts Business (2016-2021)
11.3.5 ITL Limited Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Leukocarts Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 24 Hooks Leukocarts
Table 3. Key Players of 48 Hooks Leukocarts
Table 4. Global Leukocarts Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Leukocarts Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Leukocarts Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Leukocarts Market Share by Regions (2016-2021)
Table 8. Global Leukocarts Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Leukocarts Market Share by Regions (2022-2027)
Table 10. Leukocarts Market Trends
Table 11. Leukocarts Market Drivers
Table 12. Leukocarts Market Challenges
Table 13. Leukocarts Market Restraints
Table 14. Global Leukocarts Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Leukocarts Market Share by Players (2016-2021)
Table 16. Global Top Leukocarts Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukocarts as of 2020)
Table 17. Ranking of Global Top Leukocarts Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Leukocarts Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Leukocarts Product Solution and Service
Table 21. Date of Enter into Leukocarts Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Leukocarts Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Leukocarts Revenue Market Share by Type (2016-2021)
Table 25. Global Leukocarts Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Leukocarts Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Leukocarts Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Leukocarts Revenue Market Share by Application (2016-2021)
Table 29. Global Leukocarts Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Leukocarts Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Leukocarts Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Leukocarts Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Leukocarts Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Leukocarts Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Leukocarts Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Leukocarts Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Leukocarts Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Leukocarts Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Leukocarts Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Leukocarts Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Leukocarts Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Leukocarts Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Leukocarts Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Leukocarts Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Leukocarts Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Leukocarts Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Leukocarts Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Leukocarts Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Leukocarts Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Leukocarts Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Leukocarts Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Leukocarts Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Leukocarts Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Leukocarts Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Leukocarts Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Leukocarts Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Leukocarts Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Leukocarts Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Leukocarts Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Leukocarts Market Size by Country (2022-2027) & (US$ Million)
Table 61. Oxford Meditech Company Details
Table 62. Oxford Meditech Business Overview
Table 63. Oxford Meditech Leukocarts Product
Table 64. Oxford Meditech Revenue in Leukocarts Business (2016-2021) & (US$ Million)
Table 65. Oxford Meditech Recent Development
Table 66. Baxter Healthcare Company Details
Table 67. Baxter Healthcare Business Overview
Table 68. Baxter Healthcare Leukocarts Product
Table 69. Baxter Healthcare Revenue in Leukocarts Business (2016-2021) & (US$ Million)
Table 70. Baxter Healthcare Recent Development
Table 71. ITL Limited Company Details
Table 72. ITL Limited Business Overview
Table 73. ITL Limited Leukocarts Product
Table 74. ITL Limited Revenue in Leukocarts Business (2016-2021) & (US$ Million)
Table 75. ITL Limited Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leukocarts Market Share by Type: 2020 VS 2027
Figure 2. 24 Hooks Leukocarts Features
Figure 3. 48 Hooks Leukocarts Features
Figure 4. Global Leukocarts Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Blood Banks Case Studies
Figure 7. Other Case Studies
Figure 8. Leukocarts Report Years Considered
Figure 9. Global Leukocarts Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Leukocarts Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Leukocarts Market Share by Regions: 2020 VS 2027
Figure 12. Global Leukocarts Market Share by Regions (2022-2027)
Figure 13. Global Leukocarts Market Share by Players in 2020
Figure 14. Global Top Leukocarts Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukocarts as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Leukocarts Revenue in 2020
Figure 16. Global Leukocarts Revenue Market Share by Type (2016-2021)
Figure 17. Global Leukocarts Revenue Market Share by Type (2022-2027)
Figure 18. North America Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Leukocarts Market Share by Type (2016-2027)
Figure 20. North America Leukocarts Market Share by Application (2016-2027)
Figure 21. North America Leukocarts Market Share by Country (2016-2027)
Figure 22. United States Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Leukocarts Market Share by Type (2016-2027)
Figure 26. Europe Leukocarts Market Share by Application (2016-2027)
Figure 27. Europe Leukocarts Market Share by Country (2016-2027)
Figure 28. Germany Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Leukocarts Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Leukocarts Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Leukocarts Market Share by Region (2016-2027)
Figure 38. China Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Leukocarts Market Share by Type (2016-2027)
Figure 46. Latin America Leukocarts Market Share by Application (2016-2027)
Figure 47. Latin America Leukocarts Market Share by Country (2016-2027)
Figure 48. Mexico Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Leukocarts Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Leukocarts Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Leukocarts Market Share by Country (2016-2027)
Figure 54. Turkey Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Leukocarts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Oxford Meditech Revenue Growth Rate in Leukocarts Business (2016-2021)
Figure 58. Baxter Healthcare Revenue Growth Rate in Leukocarts Business (2016-2021)
Figure 59. ITL Limited Revenue Growth Rate in Leukocarts Business (2016-2021)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed